BioWraptor

BioWraptor is a New York platform biotechnology company that stabilizes fragile biomolecules at room temperature using naturally derived, tardigrade-inspired building blocks that form a protective wrap around them, aiming to remove cold-chain dependence for research tools, diagnostics, medicines and other biologics. It was founded by Maeva Coste and Jen Laws, and its approach builds on biomolecular stabilization research published by Coste and a City University of New York team in Nature Materials. The company is based in Long Island City, Queens, and participates in programs including Activate, NYCEDC Newlab Founder Fellows and BioTools Innovator.

  • Platform
  • Pre-Seed
  • Biotechnology
  • Cold Chain
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 12, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 12, 2026

    $1.5M

    Pre-Seed

    • NY Ventures
    • Greg Haar
    • Anima x Alpha Star
    • SNOCAP
    • Berangere Marguet
    • Pascal Marguet
    • Ryan Jeffery

    BioWraptor Raises $1.5M Pre-Seed to Stabilize Biomolecules at Room Temperature

    BioWraptor Closes $1.5M Pre Seed Round BioWraptor, a New York platform biotechnology company, has raised a $1.5 million pre seed round. The funding date is Nov…

    Read article

Pricing

Research BioWraptor — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if BioWraptor is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational